Beating the Bug―Securing Effective Antibiotics

The Embassy of Sweden, in collaboration with AstraZeneca and theExtending the Cure project at Resources for the Future, invite you to a lunch seminar on antibiotic resistance, a matter of global concern and one of today's most pressing health issues.

Date

April 14, 2010

Time

12:00–2:00 p.m. ET

Event Series

Workshop

The Embassy of Sweden, in collaboration with AstraZeneca and the Extending the Cure project at Resources for the Future, invite you to a lunch seminar on antibiotic resistance, a matter of global concern and one of today's most pressing health issues. How can we secure treatment of future infectious diseases and solve the issues from overuse of current antibiotics? The seminar will discuss actions, innovations and incentives needed to create pharmaceuticals that can beat the superbugs.

This seminar is part of the "Health & Care" spring program running at House of Sweden in Washington DC, from March 25th to June 6th.

Light lunch 11:30 am

RSVP by April 9, 2010
to [email protected]

Moderator

Dr. Ramanan Laxminarayan, Senior Fellow, Resources for the Future

Speakers

Mr. David Brennan, CEO, AstraZeneca and Former Chairman of PhRMA Professor

Otto Cars, Professor of Infectious Diseases, Uppsala University and Chairman of ReAct (Action on Antibiotic Resistance)

Dr. Chantal Morel, London School of Economics

Dr. Edward Cox, Director, Office of Antimicrobial Products, U.S. Food and Drug Administration

Dr. John G. Bartlett, John Hopkins University School of Medicine representing the Infectious Diseases Society of America

Related Content